vimarsana.com
  1. Home
  2. Live Updates
  3. Fragilex Conference July - Breaking News

Latest Breaking News On - Fragilex conference july - Page 1 : vimarsana.com

Allos Pharma Inc Receives FDA Guidance for the Design of a Phase 3 Trial to Support a New Drug Application for Treatment of Fragile X Syndrome

/PRNewswire/ Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,.

United kingdomKatie clappHilary rosselotDrug administrationNational fragilex foundationPrnewswire allos pharma incClinical trial committeeAllos pharma incInternational fragilex conferenceResearch foundationNew drug applicationFragilex syndromeExecutive directorRandall carpenterAllos pharmaFragilex conference july

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.